Mayo Clinic to test adult stem cells to treat heart failure

Jan. 17, 2014 at 11:37 PM   |   Comments

ROCHESTER, Minn., Jan. 17 (UPI) -- The U.S. Food and Drug Administration approved a clinical trial of heart failure patients to determine if using stem cells improves the heart, researchers say.

Dr. Andre Terzic, director of the Mayo Clinic's Center for Regenerative Medicine in Rochester, Minn., said the decade-long project using stem cells to repair -- "cure" -- damaged heart tissue could have implications for millions of Americans with heart disease.

The trial is scheduled to involve 240 heart failure patients from 40 hospitals in Europe and Israel.

The procedure could be a "paradigm shift" in the treatment of heart disease, Terzic told the (Minneapolis) Star Tribune.

The process, developed in collaborations with Cardio3 BioSciences of Belgium, involves harvesting stem cells from a patient's bone marrow in the hip, directing the cells to become "cardiopoietic" repair cells, then injecting them back into the heart to repair heart damage.

Dr. Atta Behfar, a researcher on Terzic's team, isolated hundreds of proteins involved in the transcription process that takes place when stem cells are converted to heart cells and identified eight proteins crucial to the process.

Early results are expected in 2015.

© 2014 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Most Popular
Fewer prescription pill overdoses in medical marijuana states
New data shows Melbourne is most well-rested city in the world
New research details rare cancer that killed Bob Marley
Poll: 26 percent of Americans believe they will get Ebola
Daughters more likely than sons to care for elder parents
Trending News